Veeva Systems Inc (BSP:V2EE34)
R$ 35.08 0 (0%) Market Cap: 170.25 Bil Enterprise Value: 149.86 Bil PE Ratio: 65.65 PB Ratio: 7.34 GF Score: 80/100

Veeva Systems Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2024 / 10:15PM GMT
Release Date Price: R$30
Anne Elizabeth Samuel
JPMorgan Chase & Co, Research Division - Analyst

Good afternoon, everyone, and welcome to the JPMorgan Healthcare Conference. My name is Anne Samuel, and I cover health care technology and distribution here at JPMorgan. We're thrilled to have Veeva with us presenting today. With us are CEO, Peter Gassner, and CFO, Brent Bowman. They're going to do a brief presentation, and then my associate, [Kyle], is going to help out with the Q&A.

So with that, let me turn it over to Peter.

Peter P. Gassner
Veeva Systems Inc. - Founder, CEO & Director

Hello, folks. Can you hear me okay? All right. Third day of JPM, you've got some rain and you got some wind. You've had a lot of meetings. Some of you may be introverts, so your brains might be mush like mine right now. So you never know what you're going to get from me in this situation, but I'll try to explain a little bit about Veeva.

And maybe you also might pick up something about the industry as well because our customers are pharma and biotech customers, and I talk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot